AFXA fundamentals
An in-depth look to CARL ZEISS MEDITEC ADR 1 operating, investing, and financing activities
AFXA free cash flow for H1 24 is 12.03 M EUR. For 2023, AFXA free cash flow was 186.88 M EUR and operating cash flow was 253.12 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM